COPENHAGEN (MedPage Today) -- Patients with secondary progressive multiple sclerosis who stayed on cyclophosphamide therapy had a lower risk of further disability, but their dropout rate was high, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment